Multiple law firms are investigating potential securities-law claims after HCA cut its 2026 profit outlook and said an unfavorable payer mix reduced quarterly revenue by about $400 million.
Kessler Topaz Meltzer & Check, LLP, Bragar Eagel & Squire, P.C., and now the Portnoy Law Firm have announced investigations into potential securities-law claims involving HCA Healthcare, Inc. after the company’s July 14, 2026 preliminary second-quarter results lowered full-year earnings guidance. HCA said an adverse shift in payer mix, driven by a rise in uninsured patient visits as individuals lost coverage through health insurance marketplaces, reduced quarterly revenue by roughly $400 million. The company cut its 2026 earnings outlook to $28.70 to $30.50 per share, narrowed revenue guidance to $77 billion to $79.5 billion from a prior $76.5 billion to $80 billion, and lowered adjusted EBITDA expectations to $15.4 billion to $16.1 billion from $15.55 billion to $16.45 billion. Following the disclosure, HCA shares fell $27.14, or 6.95%, to close at $363.60 on July 14. The firms said they are seeking information from investors who purchased HCA securities and suffered losses.